Shattuck Labs (STTK) CTO sells shares after option exercise under 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Shattuck Labs Chief Technical Officer Abhinav A. Shukla reported an option exercise and related share sale. He exercised stock options for 2,032 shares of common stock at an exercise price of $3.57 per share and sold 2,032 shares in an open-market transaction at a weighted average price of $7.01 per share.
The transactions were carried out under a Rule 10b5-1 trading plan adopted on February 2, 2026, designed to sell shares received from option exercises only as needed to fund exercise costs and estimated tax withholding. Following these transactions, he directly holds 81,258 shares of common stock and 50,168 stock options.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 2,032 shares ($14,244)
Net Sell
3 txns
Insider
Shukla Abhinav A.
Role
Chief Technical Officer
Sold
2,032 shs ($14K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 2,032 | $0.00 | -- |
| Exercise | Common Stock | 2,032 | $3.57 | $7K |
| Sale | Common Stock | 2,032 | $7.01 | $14K |
Holdings After Transaction:
Stock Option (Right to Buy) — 50,168 shares (Direct, null);
Common Stock — 83,290 shares (Direct, null)
Footnotes (1)
- Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2026. The plan is intended to execute sales of shares received upon option exercise only as needed to fund the exercise price and estimated tax withholding associated with option exercises under the plan. Under the procedures of the administering broker, acquired shares are first sold to fund the aggregate exercise price and estimated tax withholding with respect to all possible option exercises in a particular order under the plan and only once fully funded will acquired shares be held by the Reporting Person. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.00 to $7.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. This option represents a right to purchase a total of 52,200 shares of the Issuer's common stock, one quarter of which will vest on January 25, 2024, with the remaining three quarters vesting in equal monthly installments through January 25, 2027, subject to the Reporting Person's continued service to the Issuer.
Key Figures
Shares sold: 2,032 shares
Sale price (weighted average): $7.01 per share
Shares acquired via exercise: 2,032 shares
+5 more
8 metrics
Shares sold
2,032 shares
Common stock sold in open-market transaction on May 12, 2026
Sale price (weighted average)
$7.01 per share
Weighted average price; trades ranged from $7.00 to $7.02
Shares acquired via exercise
2,032 shares
Common stock acquired by option exercise at $3.57 per share
Option exercise price
$3.57 per share
Exercise price for stock options converted into common stock
Shares held after
81,258 shares
Direct common stock ownership following reported transactions
Options remaining
50,168 options
Stock options outstanding after exercising 2,032 options
Total option grant size
52,200 shares
Stock option grant subject to vesting through January 25, 2027
Rule 10b5-1 plan adoption date
February 2, 2026
Plan governing sales to fund option exercises and taxes
Key Terms
Rule 10b5-1 trading plan, weighted average price, Stock Option (Right to Buy), exercise price, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported above is a weighted average price. The shares were sold in multiple transactions"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) ... represents a right to purchase a total of 52,200 shares"
exercise price financial
"The plan is intended to execute sales of shares received upon option exercise only as needed to fund the exercise price"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"one quarter of which will vest on January 25, 2024, with the remaining three quarters vesting in equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What options did the Shattuck Labs (STTK) CTO exercise in this Form 4?
He exercised stock options covering 2,032 shares of common stock at an exercise price of $3.57 per share. These options are part of a grant representing rights to purchase 52,200 shares, with vesting from January 25, 2024 through January 25, 2027.
Was the Shattuck Labs (STTK) CTO sale part of a Rule 10b5-1 plan?
Yes. The filing states the sale occurred under a Rule 10b5-1 trading plan adopted on February 2, 2026. The plan is intended to sell shares received from option exercises only to fund the exercise price and estimated tax withholding obligations.
What is the structure of the CTO’s Shattuck Labs (STTK) stock option grant?
The option grant covers 52,200 shares of common stock. One quarter vested on January 25, 2024, and the remaining three quarters vest in equal monthly installments through January 25, 2027, subject to his continued service with Shattuck Labs.